Rapamycin Holdings, Inc.
16601 Blanco Road
Suite #120
San Antonio
Texas
78232
United States
Tel: 210-710-2867
Website: http://rapamycinholdings.com
Email: info@rapamycinholdings.com
About Rapamycin Holdings, Inc.
Rapamycin, founded in 2012 as an outgrowth of research by scientists from UT Health San Antonio and other research centers in Maine and Michigan, was previously focused on using its eRapa compound in a veterinary medicine.YEAR FOUNDED:
2012
LEADERSHIP:
Founder: Randy Goldsmith
CEO: Dan Hargrove
CFO: Mark Horsey
CMO: George Peoples
3 articles about Rapamycin Holdings, Inc.
-
BioSpace Movers and Shakers: March 1
3/1/2019
Pharma and biotech companies make changes to leadership roles, with new hires at Agios, Notable, Rapamycin, Confo, AVEO and more. -
Rapamycin Holdings, Inc. Opens First Human Clinical Trial of its eRapaTM Compound Targeting Early Stage Prostate Cancer
9/18/2018
First-ever human use of eRapa in clinical trial at UT Health San Antonio MD Anderson Cancer Center will test safety, effective dose and tolerability in early-stage prostate cancer patients, and explore how the drug could boost the immune system for a multitude of age-related diseases
-
New CEO Takes Over Rapamycin, Leads Funding Round With Plans for IND
8/8/2017